Safety and efficacy of fluticasone furoate/vilanterol trifenatate (FFVI) in COPD patients
J. Lötvall, P. Bakke, L. Bjermer, S. Steinshamn, C. Crim, L. Sanford, C. Scott-Wilson, B. Haumann (Gothenberg, Lund, Sweden; Bergen, Trondheim, Norway; RTP, United States Of America; London, United Kingdom)
Source: Annual Congress 2010 - Bronchodilators in airways disease
Session: Bronchodilators in airways disease
Session type: Oral Presentation
Number: 5556
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Lötvall, P. Bakke, L. Bjermer, S. Steinshamn, C. Crim, L. Sanford, C. Scott-Wilson, B. Haumann (Gothenberg, Lund, Sweden; Bergen, Trondheim, Norway; RTP, United States Of America; London, United Kingdom). Safety and efficacy of fluticasone furoate/vilanterol trifenatate (FFVI) in COPD patients. Eur Respir J 2010; 36: Suppl. 54, 5556
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: